Washington, D.C., Aug. 7, 2022 — The Leukemia & Lymphoma Society (LLS) joins cancer patients nationwide in celebrating the passage of key healthcare reforms in the Inflation Reduction Act of 2022 by the U.S. Senate, including an out-of-pocket limit in Medicare Part D and extension of premium subsidies that have made quality insurance more affordable for lower-income patients.Read More
See full multimedia press release here.Read More
(Rye Brook, N.Y., July 15, 2022) - The Leukemia & Lymphoma Society (LLS) is dedicated to ensuring that all blood cancer patients and survivors have access to the care they need, when they need it. But for too many patients, this does not happen.Read More
Please send all media-related inquiries and interview requests to email@example.com. An LLS representative will respond as soon as possible.